1.
Bertolina C, Bertolotti M, Leporati C, De Angelis AM, Delfanti S, Cerbone L, et al. Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report. Dermatol Reports [Internet]. 2025 Jun. 17 [cited 2026 May 25];18(1). Available from: https://journals.pagepress.net/dr/article/view/10324